Haleon(HLN)—Dividend Yield: 1.90%

Sector: Pharmaceuticals and Biotechnology | Market Cap: £32,631.41 | EPIC: HLN

Haleon (LON: HLN) is the world's largest pure-play consumer health company and a relatively new addition to the FTSE 100, with a market capitalisation of approximately £32.41 billion. Spun off from GSK in 2022, Haleon owns a portfolio of leading over-the-counter health brands including Sensodyne, Panadol, Advil, Voltaren, Centrum, and Theraflu. The company operates in over 170 markets, helping billions of people manage everyday health needs through its trusted products.

Haleon's dividend yield of approximately 1.90% reflects the company's relatively young status as an independent listed company and its strategy of balancing dividend payments with debt reduction following the demerger. The company has committed to a progressive dividend policy, and as leverage reduces and earnings grow, investors can expect increasing shareholder distributions over time.

For investors seeking defensive consumer health exposure within the FTSE 100, Haleon represents a compelling pure-play opportunity. Consumer health products enjoy remarkably stable demand patterns, as people continue purchasing pain relief, oral care, and vitamin supplements regardless of economic conditions. Haleon's category-leading brands have been trusted for generations, creating deep consumer loyalty and significant barriers to competitive entry.

Haleon's growth strategy focuses on innovation, geographic expansion, and increased penetration of its products in emerging markets where consumer health spending is growing rapidly. The company's investment in digital marketing and e-commerce is driving market share gains, particularly among younger consumers. Haleon's Sensodyne toothpaste brand is the world's number one sensitivity toothpaste, while Centrum is the global leader in multivitamins. With its defensive earnings profile, strong brand portfolio, and growing market opportunities, Haleon offers FTSE 100 investors a high-quality consumer health investment with significant long-term growth potential.